Checkpoint immunotherapy for NK/T cell lymphoma—Time for a showdown?
Checkpoint immunotherapy for NK/T cell lymphoma—Time for a showdown?
About this item
Full title
Checkpoint immunotherapy for NK/T cell lymphoma—Time for a showdown?
Author / Creator
Publisher
England: Oxford University Press
Journal title
Precision Clinical Medicine, 2021-03, Vol.4 (1), p.70-72
Language
English
Formats
Publication information
Publisher
England: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Editor's note
A commentary on “Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma”.
Alternative Titles
Full title
Checkpoint immunotherapy for NK/T cell lymphoma—Time for a showdown?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8982608
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8982608
Other Identifiers
ISSN
2096-5303
E-ISSN
2516-1571
DOI
10.1093/pcmedi/pbab004
